Found: 13
Select item for more details and to access through your institution.
Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients.
- Published in:
- Drug Safety, 2020, v. 43, n. 12, p. 1297, doi. 10.1007/s40264-020-00994-5
- By:
- Publication type:
- Article
Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology.
- Published in:
- Drug Safety, 2020, v. 43, n. 12, p. 1223, doi. 10.1007/s40264-020-00989-2
- By:
- Publication type:
- Article
Temelimab, an IgG4 Anti-Human Endogenous Retrovirus Monoclonal Antibody: An Early Development Safety Review.
- Published in:
- Drug Safety, 2020, v. 43, n. 12, p. 1287, doi. 10.1007/s40264-020-00988-3
- By:
- Publication type:
- Article
Current Evidence on Abuse and Misuse of Gabapentinoids.
- Published in:
- Drug Safety, 2020, v. 43, n. 12, p. 1235, doi. 10.1007/s40264-020-00985-6
- By:
- Publication type:
- Article
Ipilimumab-Induced Enterocolitis: A Systematic Review and Meta-Analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis.
- Published in:
- Drug Safety, 2020, v. 43, n. 12, p. 1277, doi. 10.1007/s40264-020-00975-8
- By:
- Publication type:
- Article
An Evaluation of Postmarketing Reports of Serious Idiosyncratic Liver Injury Associated with Ulipristal Acetate for the Treatment of Uterine Fibroids.
- Published in:
- Drug Safety, 2020, v. 43, n. 12, p. 1267, doi. 10.1007/s40264-020-00960-1
- By:
- Publication type:
- Article
Acknowledgement to Referees.
- Published in:
- Drug Safety, 2020, v. 43, n. 12, p. 1195, doi. 10.1007/s40264-020-01019-x
- Publication type:
- Article
Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study.
- Published in:
- Drug Safety, 2020, v. 43, n. 12, p. 1315, doi. 10.1007/s40264-020-01013-3
- By:
- Publication type:
- Article
Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney Disease.
- Published in:
- Drug Safety, 2020, v. 43, n. 12, p. 1211, doi. 10.1007/s40264-020-01010-6
- By:
- Publication type:
- Article
Liver Injury Associated with the Selective Progesterone Modulator Ulipristal.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Assessing the Safety of COVID-19 Vaccines: A Primer.
- Published in:
- Drug Safety, 2020, v. 43, n. 12, p. 1205, doi. 10.1007/s40264-020-01002-6
- By:
- Publication type:
- Article
Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports.
- Published in:
- Drug Safety, 2020, v. 43, n. 12, p. 1309, doi. 10.1007/s40264-020-01000-8
- By:
- Publication type:
- Article